News & Analysis on Clinical Trial Services & Contract Research And Development
Outsourcing-Pharma provides its latest round up of movements in the pharmaceutical outsourcing sector, including changes to AMRI’s leadership in India and a new VP at Covance.
The GAVI Alliance has launched an advance market commitment (AMC), which is using a $1.5bn (€1.1bn) fund to ensure the supply of pneumococcal vaccine to developing countries at affordable prices.
Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.
US group DZS Software Solutions says its new web ClinPlus CTMS technology will help sponsors and CROs ensure that trial procedures are being followed and eliminate redundant study management systems.
Yissum is collaborating with Aurum, Ventures MKI to develop a nanotechnology controlled release delivery platform, which is designed to increase the bioavailability of orally administered lipophilic drugs.